Neopharma

Neopharma is a pharmaceutical company established in 2003, specializing in generic medicines, contract manufacturing, and comprehensive research and development services. Operating within the Pharmaceutical and Healthcare sectors, the company leverages its expertise to deliver integrated pharmaceutical solutions. With a location count of 5, Neopharma serves diverse markets, with its operational footprint spanning across Asia Pacific, the Middle East, and North America, reflecting a broad market reach.

The company employs a workforce ranging from 1,000 - 5,000 employees, underscoring its significant operational capacity. This team is dedicated to advancing pharmaceutical innovation and ensuring the quality of its offerings. Meet Neopharma's team to gain insight into the leadership and expertise driving its growth. Neopharma's commitment to operational excellence is further supported by its involvement in various business functions, including IT, engineering, and marketing, as suggested by its extensive hashtag data.

Neopharma's financial performance is robust, with a reported revenue of $675.1M. The company has also secured funding, including a $350,000 debt round in 2020, indicating financial stability and capacity for investment. Explore financial highlights for a detailed overview of its fiscal health and investment strategies. Its product portfolio includes pharmaceuticals, drugs, and integrated pharmaceutical solutions, positioning it as a key player in the healthcare supply chain. The company's strategic focus on B2B operations and its diverse service offerings contribute to its competitive standing in the global pharmaceutical market.